Skip to content
Sentieon logo — company profile

Sentieon

Founded 2014 United States Mountain View, United States 11 employees Series B Total: $23.80M Biotechnology, Clean Energy

General Information

Company Name Sentieon
Founded Year 2014
Location United States Mountain View, United States
Employees 11
Industries Biotechnology, Clean Energy
Funding Stage Series B
Business Model B2B, SaaS, B2B2C
Revenue Model Subscription, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Sentieon. To contact Sentieon, visit sentieon.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sentieon compare?

A PDF of Sentieon and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sentieon soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sentieon

Sentieon, founded in 2014, is a promising player in the Biotechnology and Clean Energy sectors, based in the United States. The company excels in enhancing the efficiency of bioinformatics tools, aiming to support scientists, clinicians, patients, and consumers in utilizing precise genomic information. This mission addresses the increasing demand for accuracy in genomic data interpretation, positioning them at the forefront of bioinformatics innovation.

The company's growth momentum is underscored by a successful $20.00M Series B funding round completed on 25 May 2015. This round saw participation from prominent investors including Oriza Ventures, Amino Capital, IDG Capital, Centana Growth Partners, SV Tech Ventures, Ten Coves Capital, and CLI Ventures. Their investment highlights strong confidence in Sentieon's potential and its cutting-edge solutions.

Business keywords: Bioinformatics, Genomics, Cloud-based Solutions, Life Sciences, Clinical Market, Secondary Analysis Tools, DNA Sequencing, Tumor-normal Variant Detection, Computing Efficiency, Enterprise Strength, Algorithms, Data Processing, Startup, Investment Opportunity

Services & Products

FASTQ-BAM-VCF-GVCF Processing
Sequencer-Agnostic Analysis
Accelerated Bioinformatics Tools
Short and Long Reads Analysis

Target Customers

Healthcare Providers Genomic Researchers Biotechnology Firms Pharmaceutical Companies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $20.00M 7
Oriza Ventures, Amino Capital +5
25 May 2015
Series A $3.80M 3
Chiesi Ventures, Boehringer Ingelheim Venture Fund +1
04 Apr 2014

Sentieon Alternatives & Competitors

Sentieon vs

Personalized Genomics For A Healthier Future

Acquired
643 employees
Biotechnology, Health Care
Sentieon vs
Blue Bee, Inc.
Blue Bee, Inc. United States

Blue Bee is a e-commerce website and small group of specialty designer / contemporary clothing and a...

Series A
5 employees
Biotechnology, Computing

FAQ About Sentieon

Sentieon's software dramatically improves the performance of bioinformatics tools. Our mission is to help enable scientists, clinicians, patients, and consumers to better benefit from accurate genomic information.
Sentieon was founded in 2014.
Sentieon is headquartered in Mountain View, United States.
Sentieon operates in Biotechnology and Clean Energy. Its work centres on Bioinformatics, Genomics, Cloud-based Solutions and Life Sciences. Its customers include Healthcare Providers, Genomic Researchers and Biotechnology Firms.
Sentieon has a B2B, SaaS and B2B2C business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
Sentieon has approximately 11 employees.
Sentieon has completed 2 funding rounds, raising a total of $23.80M. The latest funding stage is Series B.
Sentieon offers: FASTQ-BAM-VCF-GVCF Processing, Sequencer-Agnostic Analysis, Accelerated Bioinformatics Tools, Short and Long Reads Analysis.
Top alternatives and competitors to Sentieon include Strand Life Sciences, Blue Bee, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sentieon and Strand Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sentieon, https://bouncewatch.com/company/sentieon, updated 20 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout